HSBC Funding the Future Survey | HSBC New Zealand (2024)

  • Article
  • Venture capital investors expect a pickup in activity after two tough years, according to our new HSBC survey
  • Both institutional and VC investors are optimistic on tech and healthcare but have different perceptions of risks and opportunities
  • We explore catalysts, exit strategies, IPO outlook, and more influential high-growth sectors

Investor views on high-growth sectors and venture capital

Increase in VC activity anticipated

Venture capital (VC) is back in business, according to HSBC’s inaugural Funding the Future Survey. Nearly 80% of the private investors we surveyed expect a pickup in VC activity over the next 12 months.

Our new survey provides proprietary insights into investor views on VC, private equity (PE) and listed high-growth sectors. A total of 204 market professionals took part in this first edition, representing more than USD2.3trn in assets, of which the VC/PE market made up USD507bn. The fieldwork was carried out between 11 March and 12 April 2024.

While venture capital is a significant sector in its own right, its wider influence on public markets is a key reason why we aim to give a window into the world of VC investors – their outlook, positioning, strategies, and plans. By also asking questions of investors who focus primarily on listed companies, we believe our survey offers a rich perspective on high-growth sectors.

HSBC Funding the Future Survey | HSBC New Zealand (2)

HSBC’s Funding the Future provides valuable insights at what could be a pivotal moment for the VC market:

  • Confidence and momentum: The overall investor sentiment on the VC sector is bullish. Alongside a clear expectation that VC market activity will pick up, investors think fundraising conditions are set to improve. If these expectations are borne out, it could mark a turning point for the sector.
  • Growth potential: VC investors say they have most exposure to information technology (IT), financials, and healthcare, which are sectors often perceived as having the potential for fast growth. IT is the clear standout in terms of overweight positioning on the significant interest in artificial intelligence (AI).
  • Listed tech investors love AI: Listed tech investors are optimistic, with over 90% bullish or neutral on the sector. AI, cloud, and datacentres are the most favourable investment theme for listed investors.
  • Biopharma optimism: The majority of respondents invested in listed healthcare said they are overweight the sector. For VC healthcare investors, biopharma and health-tech are the preferred sectors.
  • Exit velocity: More than three quarters of private investors plan to exit companies in their portfolios in the next 12 months, perhaps reflecting the recent resilience of global equities; the US is overwhelmingly their favoured location for taking VC investments public. The majority also expect IPO activity to pick up over the next 12 months.
  • Risks and catalysts: Political risks are the greatest concern of VC and listed investors, according to the survey, just ahead of the global rates environment. VC respondents see ESG as a tailwind rather than a headwind.

HSBC Funding the Future Survey | HSBC New Zealand (3)

Would you like to find out more? We are holding a Live Insights event on 23 May to discuss the report’s key findings, streamed exclusively on our LinkedIn channel. You will also have the chance to ask your own questions. Click here to find out more and to register.

To learn more about HSBC Global Research, please email us at AskResearch@hsbc.com

The following analyst(s), who is(are) primarily responsible for this document, certifies(y) that the opinion(s), views or forecasts expressed herein accurately reflect their personal view(s) and that no part of their compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report: Shiva Joon, CFA

This document has been issued by the Research Department of HSBC.

HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments, both equity and debt (including derivatives) of companies covered in HSBC Research on a principal or agency basis or act as a market maker or liquidity provider in the securities/instruments mentioned in this report.

Analysts, economists, and strategists are paid in part by reference to the profitability of HSBC which includes investment banking, sales & trading, and principal trading revenues.

Whether, or in what time frame, an update of this analysis will be published is not determined in advance.

For disclosures in respect of any company mentioned in this report, please see the most recently published report on that company available at www.hsbcnet.com/research.

Additional disclosures

  1. This report is dated as at 29 April 2024.
  2. All market data included in this report are dated as at close 12 April 2024, unless a different date and/or a specific time of day is indicated in the report.
  3. HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC's analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC's Investment Banking business. Information Barrier procedures are in place between the Investment Banking, Principal Trading, and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner.
  4. You are not permitted to use, for reference, any data in this document for the purpose of (i) determining the interest payable, or other sums due, under loan agreements or under other financial contracts or instruments, (ii) determining the price at which a financial instrument may be bought or sold or traded or redeemed, or the value of a financial instrument, and/or (iii) measuring the performance of a financial instrument or of an investment fund.

This document has been issued by HSBC Bank plc, which has based this document on information obtained from sources it believes to be reliable but which it has not independently verified. Neither HSBC Bank plc nor any member of its group companies (“HSBC”) make any guarantee, representation or warranty nor accept any responsibility or liability as to the accuracy or completeness of this document and is not responsible for errors of transmission of factual or analytical data, nor is HSBC liable for damages arising out of any person’s reliance on this information. The information and opinions contained within the report are based upon publicly available information at the time of publication, represent the present judgment of HSBC and are subject to change without notice.

This document is not and should not be construed as an offer to sell or solicitation of an offer to purchase or subscribe for any investment or other investment products mentioned in it and/or to participate in any trading strategy. It does not constitute a prospectus or other offering document. Information in this document is general and should not be construed as personal advice, given it has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on it, consider the appropriateness of the information, having regard to their objectives, financial situation and needs. If necessary, seek professional investment and tax advice.

The decision and responsibility on whether or not to purchase, subscribe or sell (as applicable) must be taken by the investor. In no event will any member of the HSBC group be liable to the recipient for any direct or indirect or any other damages of any kind arising from or in connection with reliance on any information and materials herein.

Past performance is not necessarily a guide to future performance. The value of any investment or income may go down as well as up and you may not get back the full amount invested. Where an investment is denominated in a currency other than the local currency of the recipient of the research report, changes in the exchange rates may have an adverse effect on the value, price or income of that investment. In case of investments for which there is no recognised market it may be difficult for investors to sell their investments or to obtain reliable information about its value or the extent of the risk to which it is exposed. Some of the statements contained in this document may be considered forward looking statements which provide current expectations or forecasts of future events. Such forward looking statements are not guarantees of future performance or events and involve risks and uncertainties. Actual results may differ materially from those described in such forward-looking statements as a result of various factors.

This document is for information purposes only and may not be redistributed or passed on, directly or indirectly, to any other person, in whole or in part, for any purpose. The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. By accepting this report, you agree to be bound by the foregoing instructions. If this report is received by a customer of an affiliate of HSBC, its provision to the recipient is subject to the terms of business in place between the recipient and such affiliate. The document is intended to be distributed in its entirety. Unless governing law permits otherwise, you must contact a HSBC Group member in your home jurisdiction if you wish to use HSBC Group services in effecting a transaction in any investment mentioned in this document.

Certain investment products mentioned in this document may not be eligible for sale in some states or countries, and they may not be suitable for all types of investors. Investors should consult with their HSBC representative regarding the suitability of the investment products mentioned in this document.

HSBC and/or its officers, directors and employees may have positions in any securities in companies mentioned in this document. HSBC may act as market maker or may have assumed an underwriting commitment in the securities of companies discussed in this document (or in related investments), may sell or buy securities and may also perform or seek to perform investment banking or underwriting services for or relating to those companies and may also be represented on the supervisory board or any other committee of those companies.

From time to time research analysts conduct site visits of covered issuers. HSBC policies prohibit research analysts from accepting payment or reimbursem*nt for travel expenses from the issuer for such visits.

HSBC Bank plc is registered in England No 14259, is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority and is a member of the London Stock Exchange. (070905)

© Copyright 2024, HSBC Bank plc, ALL RIGHTS RESERVED. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, on any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of insert issuing entity name. MCI (P) 061/09/2023, MCI (P) 073/10/2023, MCI (P) 007/10/2023, MCI (P) 008/01/2024

  • Global Research
    • General Research Insights
    • Disruptive technology
HSBC Funding the Future Survey | HSBC New Zealand (2024)

References

Top Articles
Latest Posts
Article information

Author: Horacio Brakus JD

Last Updated:

Views: 6118

Rating: 4 / 5 (51 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Horacio Brakus JD

Birthday: 1999-08-21

Address: Apt. 524 43384 Minnie Prairie, South Edda, MA 62804

Phone: +5931039998219

Job: Sales Strategist

Hobby: Sculling, Kitesurfing, Orienteering, Painting, Computer programming, Creative writing, Scuba diving

Introduction: My name is Horacio Brakus JD, I am a lively, splendid, jolly, vivacious, vast, cheerful, agreeable person who loves writing and wants to share my knowledge and understanding with you.